Subscribe to RSS

DOI: 10.1055/a-2644-0279
A Comparison of Severe Maternal Morbidity After Pre- and Periviable Premature Prelabor Rupture of Membranes in Multiple Gestations: Expectant Management versus Pregnancy Termination
Funding M.A.T., MD, was supported in part by Johns Hopkins University (5K12HD103036) and has sponsor-initiated research funding from Sage Therapeutics, Inc. unrelated to this study.

Abstract
Objective
To compare severe maternal morbidity (SMM) and mortality after pre- or periviable prelabor rupture of membranes (pPPROM) in multiple gestation pregnancies among individuals choosing expectant management (EM) or termination of pregnancy (TOP).
Study Design
A retrospective cohort study of multiple gestations with pPPROM between 140/7 and 236/7 at five hospitals within a large health system from 2011 to 2024. The primary outcome was SMM by the Centers for Disease Control (CDCs), 21 indicators compared between the two cohorts. Continuous outcomes were compared with Mann–Whitney U tests. Chi-square/Fisher's exact tests were used for categorical outcomes. Data was analyzed using R.
Results
Forty-five twin and 1 triplet gestations were included (n = 37 EM, n = 9 TOP). There were no differences in gestational age at PPROM, age, race, and history of PPROM. There were no maternal deaths and no differences in chorioamnionitis, sepsis, ICU admission, blood loss, or hospital readmission. Seventy point three percent of patients undergoing EM experienced some form of maternal morbidity, and 27.0% experienced at least one CDC SMM indicator, but this was not different between groups.
Conclusion
One in four individuals with multiple gestations undergoing EM of pPPROM experienced at least one adverse maternal outcome by CDC criteria. There were no significant differences identified between EM and TOP, likely due to the study's limited size.
Key Points
-
More than 70% of multiples with pPPROM electing EM experienced an adverse maternal outcome.
-
There was no difference in maternal morbidity detected between EM and termination.
-
One in four multiples with pPPROM electing EM had a severe adverse maternal outcome.
-
Given disparities in access to termination, understanding maternal risks of pPPROM is critical.
Keywords
maternal morbidity - maternal complications - adverse outcomes - preterm prelabor rupture of membranes - multiple gestationPublication History
Received: 26 April 2025
Accepted: 11 June 2025
Accepted Manuscript online:
27 June 2025
Article published online:
09 July 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Sklar A, Sheeder J, Davis AR, Wilson C, Teal SB. Maternal morbidity after preterm premature rupture of membranes at <24 weeks' gestation. Am J Obstet Gynecol 2022; 226 (04) 558.e1-558.e11
- 2 Battarbee AN, Osmundson SS, McCarthy AM, Louis JM. Society for Maternal-Fetal Medicine (SMFM), SMFM Publications Committee. Electronic address: pubs@smfm.org. Society for Maternal-Fetal Medicine Consult series #71: management of previable and periviable preterm prelabor rupture of membranes. Am J Obstet Gynecol 2024; 231 (04) B2-B15
- 3 Dotters-Katz SK, Panzer A, Grace MR. et al. Maternal morbidity after previable prelabor rupture of membranes. Obstet Gynecol 2017; 129 (01) 101-106
- 4 Lorthe E, Torchin H, Delorme P. et al. Preterm premature rupture of membranes at 22-25 weeks' gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2). Am J Obstet Gynecol 2018; 219 (03) 298.e1-298.e14
- 5 Sim WH, Ng H, Sheehan P. Maternal and neonatal outcomes following expectant management of preterm prelabor rupture of membranes before viability. J Matern Fetal Neonatal Med 2020; 33 (04) 533-541
- 6 Kibel M, Asztalos E, Barrett J. et al. Outcomes of pregnancies complicated by preterm premature rupture of membranes between 20 and 24 weeks of gestation. Obstet Gynecol 2016; 128 (02) 313-320
- 7 Wagner P, Sonek J, Mayr S. et al. Outcome of dichorionic diamniotic twin pregnancies with spontaneous PPROM before 24 weeks' gestation. J Matern Fetal Neonatal Med 2017; 30 (14) 1750-1754
- 8 Goodfellow L, Care A, Curran C. et al. Preterm prelabour rupture of membranes before 23 weeks' gestation: prospective observational study. BMJ Med 2024; 3 (01) e000729
- 9 Abrahami Y, Saucedo M, Rigouzzo A, Deneux-Tharaux C, Azria E. ENCMM group. Maternal mortality in women with pre-viable premature rupture of membranes: an analysis from the French confidential enquiry into maternal deaths. Acta Obstet Gynecol Scand 2022; 101 (12) 1395-1402
- 10 Identifying SMM. (SMM). Centers for Disease Control and Prevention (CDC). Updated May 15, 2024. Accessed January 24, 2025 at: https://www.cdc.gov/maternal-infant-health/php/severe-maternal-morbidity/icd.html
- 11 Sorrenti S, Di Mascio D, Khalil A. et al. Outcome of prelabor rupture of membranes before or at the limit of viability: systematic review and meta-analysis. Am J Obstet Gynecol MFM 2024; 6 (06) 101370
- 12 Committee Opinion No. Committee opinion no. 712: intrapartum management of intraamniotic infection. Obstet Gynecol 2017; 130 (02) e95-e101
- 13 ACOG Clinical Practice Update. Update on criteria for suspected diagnosis of intraamniotic infection. Obstet Gynecol 2024; 144 (01) e17-e19
- 14 Singer M, Deutschman CS, Seymour CW. et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 2016; 315 (08) 801-810
- 15 Plante LA, Pacheco LD, Louis JM. Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org. SMFM consult series #47: sepsis during pregnancy and the puerperium. Am J Obstet Gynecol 2019; 220 (04) B2-B10
- 16 von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. STROBE Initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61 (04) 344-349
- 17 Binstock A, Bodnar LM, Himes KP. Severe maternal morbidity in twins. Am J Perinatol 2023; 40 (07) 704-710
- 18 Young BC, Wylie BJ. Effects of twin gestation on maternal morbidity. Semin Perinatol 2012; 36 (03) 162-168
- 19 Madar H, Goffinet F, Seco A, Rozenberg P, Dupont C, Deneux-Tharaux C. EPIMOMS (EPIdémiologie de la MOrbidité Maternelle Sévère) Study Group. Severe acute maternal morbidity in twin compared with singleton pregnancies. Obstet Gynecol 2019; 133 (06) 1141-1150
- 20 Santana DS, Cecatti JG, Surita FG. et al; WHO Multicountry Survey on Maternal and Newborn Health Research Network. Twin pregnancy and severe maternal outcomes: the World Health Organization multicountry survey on maternal and newborn health. Obstet Gynecol 2016; 127 (04) 631-641
- 21 Breslin N, Jacob T, Baptiste C. et al. Pre- and periviable PPROM after fetoscopic laser surgery: are survival outcomes better than we think?. Fetal Diagn Ther 2024; 51 (06) 594-602
- 22 Forde B, Fresch R, Masters H. et al. Comparison of pregnancy outcomes of previable and periviable rupture of membranes after laser photocoagulation for twin-twin transfusion syndrome. Obstet Gynecol 2022; 140 (06) 965-973
- 23 Forde B, Habli M. Unique considerations: preterm prelabor rupture of membranes in the setting of fetal surgery and higher order pregnancies. Obstet Gynecol Clin North Am 2020; 47 (04) 653-669
- 24 Nehme L, Ye P, Huang JC, Kawakita T. Decision and economic analysis of hostile abortion laws compared with supportive abortion laws. Am J Obstet Gynecol MFM 2023; 5 (08) 101019
- 25 Verma N, Shainker SA. Maternal mortality, abortion access, and optimizing care in an increasingly restrictive United States: a review of the current climate. Semin Perinatol 2020; 44 (05) 151269
- 26 Arey W, Lerma K, Carpenter E. et al. Abortion access and medically complex pregnancies before and after texas senate bill 8. Obstet Gynecol 2023; 141 (05) 995-1003